NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/22/2025
Back to search
Official data from USPTO
S
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
07/22/2025
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
01/07/2022
Registration date
07/22/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/22/2025
Last transaction
07/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2022
First use in commerce
03/01/2022
Drawing code
3
Owner type
03
Owner location
Cambridge, MA, US
Examiner
ARRISON, RACHEL MARIE
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized double helix design which incorporates a stylized letter "S".
Holders and representatives
Holders
Editas Medicine, Inc.
Representatives
Timothy H. Hiebert WOMBLE BOND DICKINSON (US) LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use
Publications
History of USPTO decisions and trademark events.
35 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/22/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/16/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/27/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/03/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/02/2025
EISU
TEAS STATEMENT OF USE RECEIVED
03/10/2025
IUAF
USE AMENDMENT FILED
03/09/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/09/2024
EX3G
SOU EXTENSION 3 GRANTED
09/09/2024
EXT3
SOU EXTENSION 3 FILED
09/09/2024
EEXT
SOU TEAS EXTENSION RECEIVED
09/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/14/2024
EX2G
SOU EXTENSION 2 GRANTED
03/13/2024
EXT2
SOU EXTENSION 2 FILED
03/13/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/13/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/18/2023
EX1G
SOU EXTENSION 1 GRANTED
07/14/2023
EXT1
SOU EXTENSION 1 FILED
07/14/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/14/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/17/2023
PUBO
PUBLISHED FOR OPPOSITION
01/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/28/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/15/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/13/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/12/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/25/2022
GNRT
NON-FINAL ACTION E-MAILED
07/25/2022
CNRT
NON-FINAL ACTION WRITTEN
07/25/2022
DOCK
ASSIGNED TO EXAMINER
07/20/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/14/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/13/2022
NWAP
NEW APPLICATION ENTERED
01/11/2022
Continuous trademark protection
Get notified about every new filing that threatens S or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.